Cairo will host the first-ever Ai Everything Middle East and Africa (MEA) from February 11 to 12, positioning Egypt as a hub for regional discussions on AI as a structural force shaping economies, governance, and society.
Organized by GITEX GLOBAL and hosted by Egypt’s Ministry of Communications and Information Technology in partnership with the Information Technology Industry Development Agency (ITIDA), the event signals a decisive shift toward applied AI, moving beyond abstract concepts to tangible solutions that intersect with industry and public service.
The launch aligns with the country’s National Artificial Intelligence Strategy 2025-2030, which places AI at the core of economic planning, public service reform, and digital autonomy.
AI in health and life sciences
AI DigiHealth, which explores the integration of AI and digital technologies into healthcare and life sciences, will be a central focus of the event.
AI is transforming care delivery and research by offering tools to detect diseases earlier, optimize hospital operations, and accelerate drug discovery. Advanced algorithms can analyze medical images and patient data, providing clinicians with insights that improve diagnostic accuracy and enable personalized treatment.
In regions where healthcare access is uneven and demographic pressures are growing, these technologies promise new models for efficiency, early intervention, and scalable care.
AI also plays a pivotal role in hospital management and operational planning, helping institutions allocate resources more effectively, streamline patient flow, and reduce waiting times.
It meanwhile accelerates research in the biotech sector by processing vast datasets, predicting molecular interactions, and designing experiments with greater precision.
Machine learning applications in drug discovery are shortening timelines for new therapies and vaccines, which is particularly critical in addressing regional health challenges.
AI also enables predictive healthcare, allowing providers to anticipate potential risks and tailor interventions to individual patient needs.
However, these advances raise crucial questions around data governance, patient privacy, and the ethical integration of AI into established medical frameworks, issues that will feature prominently during the discussions at Ai Everything MEA.
Biotech and AI: shaping the future of medicine
The convergence of AI and biotechnology shows a broader transformation in life sciences.
AI-driven tools empower researchers to tackle complex biological problems, from genetic analysis to synthetic biology, with unprecedented speed and accuracy.
In the Middle East and Africa, such innovations not only open new frontiers for scientific research but also provide solutions to local healthcare challenges, such as rare genetic conditions and infectious disease outbreaks.
For countries like Egypt, leveraging AI in biotech represents an opportunity to build both global competitiveness and regional health resilience, positioning technological innovation as a structural enabler rather than a niche capability.
Collaboration and regional impact
Over two days, Ai Everything MEA will bring together enterprises, startups, policymakers, researchers, and investors from more than 60 countries.
The program emphasizes practical deployment, cross-sector collaboration, and frameworks shaped by regional realities rather than theoretical speculation.
Panels and workshops will focus on how AI can integrate with digital health systems, enhance hospital management, and accelerate biotech research, offering insights into both immediate applications and long-term strategy.
For Egypt, the event represents a concrete step in translating its national AI strategy into actionable initiatives.
For the wider Middle East and Africa, it provides a lens through which AI can be understood as infrastructure, a governance tool, an economic driver, and a cultural force. The gathering highlights a growing recognition that AI now shapes how societies operate, innovate, and envision their future.
